Home

Lynx1 Capital Management, 10% Owner: TScan Therapeutics TCRX Sell · Filed 23/06/02

Trade details

Type
Insider sale
Amount
$37,800
Shares · price
15,000 sh · $2.52 a share
Held after
5,225,000 sh
Trade date
23/05/31
Filed
23/06/02
Days to filing
2 days

Sold 0.3% of holdings

Share of holding sold
0.3%

TScan Therapeutics trades, last 26 weeks

What else happened in TScan Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/01~23/06/30

Lynx1 Capital Management's recent trades